Published in Oncotarget on August 09, 2016
A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res (2001) 124.61
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res (2002) 76.95
Cancer statistics, 2016. CA Cancer J Clin (2016) 32.95
Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med (2010) 29.75
Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med (2011) 27.58
Increased survival with enzalutamide in prostate cancer after chemotherapy. N Engl J Med (2012) 20.79
Alpha emitter radium-223 and survival in metastatic prostate cancer. N Engl J Med (2013) 13.90
The development of androgen-independent prostate cancer. Nat Rev Cancer (2001) 11.88
Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene (2005) 5.50
The cancer/testis genes: review, standardization, and commentary. Cancer Immun (2004) 4.78
The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res (1996) 1.93
Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer. Cancer Res (2011) 1.66
Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex. J Cell Biol (2012) 1.59
The biology of cancer testis antigens: putative function, regulation and therapeutic potential. Mol Oncol (2011) 1.57
The SSX gene family: characterization of 9 complete genes. Int J Cancer (2002) 1.46
alpha4beta1 integrin regulates lamellipodia protrusion via a focal complex/focal adhesion-independent mechanism. Mol Biol Cell (2002) 1.45
Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A (2010) 1.42
Neuroendocrine differentiation in human prostate cancer. Morphogenesis, proliferation and androgen receptor status. Ann Oncol (2001) 1.38
Overview of prostate-specific membrane antigen. Rev Urol (2004) 1.34
Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression. Cancer Res (2005) 1.25
Expression of SSX genes in human tumors. Int J Cancer (1998) 1.24
A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas. Oncogene (1998) 1.24
SSX and the synovial-sarcoma-specific chimaeric protein SYT-SSX co-localize with the human Polycomb group complex. Oncogene (1999) 1.22
Androgen receptor: structure, role in prostate cancer and drug discovery. Acta Pharmacol Sin (2014) 1.15
Mitomycin C: mechanism of action, usefulness and limitations. Anticancer Drugs (1990) 1.14
Annexin A1 attenuates EMT and metastatic potential in breast cancer. EMBO Mol Med (2010) 1.14
Inducible expression of a prostate cancer-testis antigen, SSX-2, following treatment with a DNA methylation inhibitor. Prostate (2007) 1.09
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available Therapies. J Urol (2015) 1.08
The SSX family of cancer-testis antigens as target proteins for tumor therapy. Clin Dev Immunol (2010) 1.06
Neuroendocrine differentiation of prostate cancer: a review. Am J Clin Exp Urol (2014) 0.98
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs. J Immunother (2005) 0.97
Vaccines targeting the cancer-testis antigen SSX-2 elicit HLA-A2 epitope-specific cytolytic T cells. J Immunother (2011) 0.97
Immune privilege or privileged immunity? Mucosal Immunol (2008) 0.96
The cancer-related protein SSX2 interacts with the human homologue of a Ras-like GTPase interactor, RAB3IP, and a novel nuclear protein, SSX2IP. Genes Chromosomes Cancer (2002) 0.95
Expression of EphA2 and E-cadherin in gastric cancer: correlated with tumor progression and lymphogenous metastasis. Pathol Oncol Res (2009) 0.92
Expression of SSX genes in the neoplastic cells of Hodgkin's lymphoma. Hum Pathol (2002) 0.90
Single cell transcriptomic analysis of prostate cancer cells. BMC Mol Biol (2013) 0.89
Overexpression of EphA2 correlates with epithelial-mesenchymal transition-related proteins in gastric cancer and their prognostic importance for postoperative patients. Med Oncol (2011) 0.89
Current Challenges in Prostate Cancer Management and the Rationale behind Targeted Focal Therapy. Adv Urol (2012) 0.87
High glucose levels inhibit focal adhesion kinase-mediated wound healing of rat peritoneal mesothelial cells. Kidney Int (2003) 0.86
The role of EPH receptors in cancer-related epithelial-mesenchymal transition. Chin J Cancer (2013) 0.85
Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells. PLoS One (2014) 0.84
Experimental metastasis assay. J Vis Exp (2010) 0.82
Cancer/testis antigen SSX2 enhances invasiveness in MCF-7 cells by repressing ERα signaling. Int J Oncol (2012) 0.81
Targeting focal adhesion turnover in invasive breast cancer cells by the purine derivative reversine. Br J Cancer (2013) 0.79
Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion. Oncol Lett (2014) 0.78